TraceLink Completes Upload Certification Tests With EMVO for Connection to the European Hub
NORTH READING, MA--(Marketwired - Mar 8, 2016) - TraceLink Inc ., the world's largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced that it has completed product master data and product pack data upload certification tests with the European Medicines Verification Organization (EMVO) for connection to the European Hub. The tests authenticate the ability for pharmaceutical manufacturers to use TraceLink's EU Compliance module, which is now commercially available, to communicate product master data and product pack data to the EU Hub, and to meet serialization and compliance requirements under the EU Falsified Medicines Directive (FMD) nearly three years in advance of the February 2019 deadline. As a result, all pharmaceutical manufacturers can leverage their single integration to the Life Sciences Cloud to automatically access the EMVO tested capabilities by setting a few configuration flags. TraceLink's unique network-tenant platform approach significantly reduces the time, cost and risk of achieving regulatory compliance for the EU FMD and all other countries that have requirements by eliminating the need to verify and certify point-to-point connections to each government system.
"Pharmaceutical companies face the difficult challenge of meeting a wide range of global regulations on-time, at the lowest cost and the least risk of ensuring drug supply without disruption to their operations. Our family of track and trace solutions now extends to the European Union with a tested EU Compliance platform that enables companies to get a jumpstart on preparing for upcoming 2019 deadlines," said Shabbir Dahod, president and CEO of TraceLink. "This milestone is the result of more than two years of design, development, and testing -- and close collaboration with the EMVO to gain a deep understanding of the complex rules and operational requirements for the Falsified Medicines Directive. With our EU Compliance module now live, TraceLink offers country-specific compliance software for more regulated geographies than any other track and trace provider."
TraceLink EU Compliance: Continuous Regulatory Support on the Most Proven Track and Trace Network
The TraceLink Life Sciences Cloud is the only track and trace solution that is proven to provide pharmaceutical manufacturers with continuous continuity of drug supply to global markets that have vastly different and highly complex serialization and regulatory compliance requirements. The EU Falsified Medicines Directive adds to this complexity as the regulation spans more than 30 countries and aims to protect approximately 900 billion doses of medicine. Pharmaceutical manufacturers that ship products to the EU and choose the Life Sciences Cloud now have access to a tested EU Compliance solution that will help to eliminate business risk and ensure drug products reach patients in the most timely and cost-effective manner. Specific benefits of using the EU Compliance module include:
- An out-of-the-box, integrated EU compliance solution for the Falsified Medicines Directive --delivering a comprehensive suite of serialization, master data, verification and compliance reporting solutions available for EU compliance;
- Tested integration with the European Hub --confirming with the EMVO that product master data and product pack data uploads are consistently accurate;
- Access to more than 1,200 CMOs --accelerating EU compliance readiness through connectivity to the world's largest collection of contract manufacturers with just a single connection to the Life Sciences Cloud platform;
- Elastic scalability to meet massive EU FMD transaction processing requirements --reducing risk by leveraging TraceLink's cost-effective and scalable native cloud architecture through Amazon Web Services; and,
- Continuous compliance monitoring and regular software updates that guarantee EU compliance coverage --keeping your track and trace and serialization solutions secure and up-to-date should regulatory rules evolve and data exchange standards mature.
To learn more about TraceLink's complete EU Falsified Medicines Directive solutions, or to discuss building to build a flexible global serialization, track and trace, and reporting platform, visit www.tracelink.com .
TraceLink is the world's largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses, including 16 of the top-20 global pharmaceutical companies, trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn , Twitter and Facebook .
Laura MacSweeney (for TraceLink)
Red Javelin Communications
Information om Marketwired
Følg pressemeddelelser fra Marketwired
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Marketwired
Algeco Scotsman20.11.2017 18:41 | pressemeddelelse
Statement Regarding Withdrawal of Complaint Filed on Behalf of Senior Unsecured Noteholders
Bombardier Inc.20.11.2017 16:02 | pressemeddelelse
Bombardier Announces a Cash Tender Offer for Any and All of its 4.75% Senior Notes due 2019
Bombardier Inc.20.11.2017 15:06 | pressemeddelelse
Bombardier Announces Launch of its New Issuance of Senior Notes due 2024
Algeco Scotsman16.11.2017 21:11 | pressemeddelelse
Statement Regarding Complaint Filed on Behalf of Senior Unsecured Noteholders
Cisco15.11.2017 22:06 | pressemeddelelse
Cisco Reports First Quarter Earnings
Algeco Scotsman15.11.2017 14:29 | pressemeddelelse
Algeco Scotsman Announces Availability of Certain Information Relating to Williams Scotsman
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum